| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 10.598 | 62.317 | 60.289 | 61.393 | 47.002 | 77.166 | 82.300 | 100.963 | 116.926 |
| Total Income - EUR | - | 10.598 | 62.364 | 60.289 | 61.487 | 47.025 | 77.181 | 107.530 | 100.977 | 116.965 |
| Total Expenses - EUR | - | 1.948 | 18.747 | 21.435 | 20.309 | 17.483 | 18.153 | 27.515 | 34.077 | 33.365 |
| Gross Profit/Loss - EUR | - | 8.650 | 43.617 | 38.854 | 41.178 | 29.542 | 59.028 | 80.015 | 66.900 | 83.600 |
| Net Profit/Loss - EUR | - | 8.438 | 42.994 | 38.251 | 40.563 | 29.106 | 58.271 | 78.961 | 66.019 | 80.618 |
| Employees | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Neurocare Health S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 33.446 | 25.920 | 18.640 | 11.637 | 4.877 | 58.146 | 45.321 | 33.132 |
| Current Assets | - | 11.121 | 16.509 | 41.951 | 42.699 | 18.638 | 54.987 | 50.585 | 45.167 | 66.185 |
| Inventories | - | 0 | 0 | 0 | 0 | 75 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 0 | -1 | -1 | 38.605 | 173 | 172 |
| Cash | - | 11.121 | 16.509 | 41.951 | 42.699 | 18.564 | 54.987 | 11.980 | 44.994 | 66.013 |
| Shareholders Funds | - | 8.483 | 46.171 | 66.723 | 59.633 | 29.170 | 58.333 | 79.023 | 66.267 | 80.865 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.638 | 3.784 | 1.148 | 1.706 | 1.106 | 1.530 | 29.707 | 24.222 | 18.453 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neurocare Health S.r.l.